Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases
暂无分享,去创建一个
T. Ulbright | E. Hattab | M. Al-Abbadi | A. Orazi | S. Amr | M. Tarawneh
[1] K. Ribeiro,et al. BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma. , 2006 .
[2] J. Sparano,et al. AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles , 2006, Modern Pathology.
[3] T. Habermann,et al. Adult B-Cell Lymphomas With Burkitt-Like Morphology Are Phenotypically and Genotypically Heterogeneous With Aggressive Clinical Behavior , 2005, The American journal of surgical pathology.
[4] S. Takenoshita,et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype , 2005, Modern Pathology.
[5] G. Ott,et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis , 2005, The Journal of pathology.
[6] S. Rosso,et al. Population-based incidence and mortality cancer trends (1986–1997) from the network of Italian cancer registries , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[7] J. Teruya-Feldstein,et al. Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy. , 2004, Journal of pediatric hematology/oncology.
[8] S. Rosso,et al. Cancer trends in Italy: figures from the cancer registries (1986-1997). , 2004, Epidemiologia e prevenzione.
[9] Gruppo Italiano Screening del Cervicocarcinoma GISCi. [Recommendations for quality control of cervico-vaginal cytology]. , 2004, Epidemiologia e prevenzione.
[10] L. Staudt,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.
[11] J. Coebergh,et al. Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. , 2003, European journal of cancer.
[12] S. Kvaløy,et al. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] F. Cavalli,et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Emili Montserrat,et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. , 2003, Blood.
[15] P. Colombat,et al. Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group. , 2002, Clinical lymphoma.
[16] S. Pileri,et al. Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics , 2002, Journal of clinical pathology.
[17] W. Yang,et al. CD10 expression in primary intestinal large B-cell lymphomas: its clinical significance. , 2002, Archives of pathology & laboratory medicine.
[18] G. MacLennan,et al. Follicular large cell lymphoma localized to the testis in children. , 2002, The Journal of urology.
[19] S. Barrans,et al. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. , 2002, Blood.
[20] Meland,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[21] L. Medeiros,et al. Primary follicular large cell lymphoma of the testis in a child. , 2009, Archives of pathology & laboratory medicine.
[22] A. Ramaioli,et al. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] H. Prince,et al. Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factors. , 2001, Clinical lymphoma.
[24] K. Molberg,et al. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma. Identification of a high-risk subset with coexpression of CD10 and bcl-2. , 2001, American journal of clinical pathology.
[25] K. Ohshima,et al. CD10 and Bcl10 expression in diffuse large B‐cell lymphoma: CD10 is a marker of improved prognosis , 2001, Histopathology.
[26] Yasodha Natkunam,et al. Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and Immunohistochemistry , 2001, Modern Pathology.
[27] C. Ross,et al. The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma. , 2001, American journal of clinical pathology.
[28] Kazumi Suzuki,et al. Primary testicular plasmacytoma with hydrocele of the testis , 2001, International journal of urology : official journal of the Japanese Urological Association.
[29] L. Larocca,et al. Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. , 2001, Blood.
[30] A. Iwashita,et al. Histologic and Immunohistologic Findings and Prognosis of 40 Cases of Gastric Large B-Cell Lymphoma , 2000, The American journal of surgical pathology.
[31] T. Naab,et al. Testicular Plasmacytoma in a Patient with the Acquired Immunodeficiency Syndrome , 2000, Tumori.
[32] H. Ohno,et al. Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6 , 2000 .
[33] P. Isaacson,et al. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. , 2000, The American journal of surgical pathology.
[34] G. Gaidano,et al. MUM1: a step ahead toward the understanding of lymphoma histogenesis , 2000, Leukemia.
[35] I. Hanamura,et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies , 2000, Leukemia.
[36] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[37] H. Ohno,et al. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. , 2000, Blood.
[38] K. Ohshima,et al. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas , 1999, Pathology international.
[39] H. Kwon,et al. Interferon regulatory factors: the next generation. , 1999, Gene.
[40] B. Szende,et al. A case of bilateral testicular lymphoma , 1999, Pathology & Oncology Research.
[41] J C Reed,et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.
[42] W. Wilson,et al. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. , 1997, Blood.
[43] S. Pileri,et al. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.
[44] D C Linch,et al. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study. , 1996, Blood.
[45] R S Chaganti,et al. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Libertino,et al. Bilateral primary non-Hodgkin's lymphoma of the testis. , 1996, Urology.
[47] G. Magoha. Bilateral primary malignant lymphoma of the testis: case report. , 1996, East African medical journal.
[48] J Diebold,et al. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA). , 1996, Blood.
[49] K. Offit,et al. BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.
[50] N. Harris,et al. Malignant Lymphoma of the Testis, Epididymis, and Spermatic Cord: A Clinicopathologic Study of 69 Cases with Immunophenotypic Analysis , 1994, The American journal of surgical pathology.
[51] S. Mushtaq,et al. Non-Hodgkin's lymphomas with primary manifestation in gonads--a clinicopathological study. , 1994, JPMA. The Journal of the Pakistan Medical Association.
[52] A. Moreau,et al. Testicular tumor and the acquired immunodeficiency syndrome. , 1994, European urology.
[53] A. Crellin,et al. Non-Hodgkin's lymphoma of the testis. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[54] C. McKiel,et al. Acquired immunodeficiency syndrome presenting as testicular lymphoma. , 1992, The Journal of urology.
[55] A. Sagalowsky,et al. Testicular tumors in men with human immunodeficiency virus. , 1992, The Journal of urology.
[56] S. Swan,et al. Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS) , 1988, American journal of epidemiology.